Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations

Authors

  • G. Y. López,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • G. A. Grant,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Surgery, Duke University Medical Center, Durham, NC, USA
    4. Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • H. E. Fuchs,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    4. Department of Surgery, Duke University Medical Center, Durham, NC, USA
    5. Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • L. G. Leithe,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Radiology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • S. Gururangan,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Surgery, Duke University Medical Center, Durham, NC, USA
    4. Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • D. D. Bigner,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • H. Yan,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • R. E. McLendon,

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author
  • Y. He

    1. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    2. The Pediatric Brain Tumor Foundation Institute, Duke University Medical Center, Durham, NC, USA
    3. Department of Pathology, Duke University Medical Center, Durham, NC, USA
    Search for more papers by this author

Ancillary